U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178925) titled 'Follow-up Cohort of Patients With Antiphospholipid Syndrome' on Sept. 10.
Brief Summary: Antiphospholipid syndrome (APLS) is a rare pathology characterized by the association of thrombotic (arterial, venous) or obstetric clinical manifestations and the persistent presence at least twelve weeks apart of antiphospholipid antibodies (APL). It is also accompanied by accelerated atherosclerosis responsible for an increased incidence of myocardial infarction, peripheral arterial disease and stroke explaining the high cardiovascular morbidity and mortality of these patients. APS can be isolated (primary) or integrated into an autoimmune p...